Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.4 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.58.
Market Cap
8.4T
Revenue
4.52T
Profits
207.08B
PE Ratio
40.58
Profit Margin
4.59%
Dividend Yield
0.43%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 853.03B | 2.39% | 2,567,999 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 581.20B | 1.21% | 8,771,118 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 374.25B | 2.53% | 5,477,736 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 317.11B | 1.72% | 2,282,880 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 304.55B | 3.27% | 9,256,857 | 65.01B |
| 6 | NVS | Novartis AG | 292.80B | 2.12% | 2,118,090 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 277.73B | -0.57% | 9,645,031 | 447.57B |
| 8 | AMGN | Amgen Inc. | 188.79B | 2.89% | 2,666,481 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 187.10B | 2.85% | 1,507,957 | 44.56B |
| 10 | ABT | Abbott Laboratories | 180.37B | 1.70% | 9,379,260 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 175.68B | 1.97% | 4,967,271 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 166.69B | 1.90% | 13,882,468 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 164.19B | 2.06% | 2,253,941 | 10.06B |
| 14 | PFE | Pfizer Inc. | 156.26B | 1.37% | 33,789,069 | 62.58B |
| 15 | DHR | Danaher Corporation | 138.84B | 2.71% | 2,610,025 | 24.57B |
| 16 | SYK | Stryker Corporation | 130.12B | 2.39% | 1,730,955 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.87B | 2.65% | 11,587,576 | 48.19B |
| 18 | SNY | Sanofi | 114.19B | 0.66% | 4,508,344 | 54.85B |
| 19 | GSK | GSK plc | 114.12B | 2.74% | 3,809,532 | 43.97B |
| 20 | MDT | Medtronic plc | 113.82B | 2.58% | 12,720,899 | 35.48B |
| 21 | HCA | HCA Healthcare, Inc. | 112.93B | 3.17% | 981,021 | 75.60B |
| 22 | VRTX | Vertex Pharmaceuticals Incorporated | 112.92B | 2.79% | 1,279,267 | 12.00B |
| 23 | MCK | McKesson Corporation | 106.71B | 1.70% | 875,725 | 397.96B |
| 24 | CVS | CVS Health Corporation | 100.98B | 0.73% | 6,758,555 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 92.98B | 1.13% | 14,972,724 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.58B | 2.01% | 580,428 | 14.34B |
| 27 | CI | The Cigna Group | 73.18B | 1.21% | 1,067,748 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 69.90B | 2.05% | 1,109,037 | 199.13B |
| 29 | COR | Cencora, Inc. | 63.21B | 1.26% | 929,722 | 325.78B |
| 30 | MDLN | Medline Inc. | 58.25B | 2.83% | 7,019,713 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.06B | 2.02% | 3,265,215 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.62B | 1.11% | 1,265,281 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 50.55B | 2.53% | 2,635,561 | 9.47B |
| 34 | ARGX | argenx SE | 48.76B | 2.57% | 316,499 | 4.24B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 47.12B | 2.96% | 451,584 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 47.11B | 1.08% | 4,664,052 | 6.07B |
| 37 | BDX | Becton, Dickinson and Company | 44.73B | 1.37% | 2,629,314 | 21.92B |
| 38 | HLN | Haleon plc | 44.19B | 0.91% | 7,984,910 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.40B | 2.42% | 1,024,695 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.77B | 3.54% | 1,750,945 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.54B | 4.06% | 6,122,402 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.62B | 2.75% | 237,508 | 5.34B |
| 43 | INSM | Insmed Incorporated | 34.58B | -1.75% | 3,356,065 | 606.42M |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.65B | 5.77% | 4,579,875 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.46B | 2.06% | 1,116,522 | 5.40B |
| 46 | A | Agilent Technologies, Inc. | 33.04B | 2.67% | 1,384,585 | 7.07B |
| 47 | WAT | Waters Corporation | 31.25B | 3.63% | 1,006,213 | 3.17B |
| 48 | NTRA | Natera, Inc. | 29.88B | 0.75% | 1,094,587 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 28.96B | 1.13% | 1,756,697 | 16.31B |
| 50 | RPRX | Royalty Pharma plc | 27.63B | 2.20% | 2,653,604 | 2.38B |
| 51 | VEEV | Veeva Systems Inc. | 27.21B | -3.45% | 1,824,155 | 3.20B |
| 52 | MTD | Mettler-Toledo International Inc. | 26.78B | 4.15% | 143,845 | 4.03B |
| 53 | PHG | Koninklijke Philips N.V. | 26.62B | 3.85% | 740,281 | 20.94B |
| 54 | BIIB | Biogen Inc. | 26.40B | 2.44% | 1,289,687 | 9.89B |
| 55 | UTHR | United Therapeutics Corporation | 25.49B | 2.83% | 575,393 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 25.32B | 4.26% | 2,807,971 | 4.66B |
| 57 | HUM | Humana Inc. | 23.82B | 0.63% | 1,985,240 | 129.66B |
| 58 | BNTX | BioNTech SE | 23.29B | 2.74% | 569,530 | 3.37B |
| 59 | LH | Labcorp Holdings Inc. | 22.64B | 2.06% | 462,388 | 13.95B |
| 60 | STE | STERIS plc | 22.07B | 2.65% | 469,674 | 5.83B |
| 61 | DGX | Quest Diagnostics Incorporated | 22.01B | 1.02% | 799,277 | 11.04B |
| 62 | MRNA | Moderna, Inc. | 20.66B | 3.97% | 4,859,873 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 20.16B | 1.51% | 3,732,289 | 13.31M |
| 64 | ILMN | Illumina, Inc. | 19.57B | 1.23% | 1,674,977 | 4.34B |
| 65 | RVMD | Revolution Medicines, Inc. | 19.17B | 0.48% | 1,203,521 | - |
| 66 | WST | West Pharmaceutical Services, Inc. | 19.15B | 2.54% | 689,413 | 3.07B |
| 67 | INCY | Incyte Corporation | 19.08B | 2.35% | 1,152,023 | 5.14B |
| 68 | CNC | Centene Corporation | 18.33B | 2.67% | 6,642,287 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 18.00B | 1.76% | 2,128,543 | 8.23B |
| 70 | THC | Tenet Healthcare Corporation | 17.34B | 2.44% | 1,699,771 | 21.31B |
| 71 | GMAB | Genmab A/S | 17.17B | 2.71% | 1,838,660 | 3.72B |
| 72 | VTRS | Viatris Inc. | 15.80B | 3.12% | 6,629,402 | 14.30B |
| 73 | MEDP | Medpace Holdings, Inc. | 14.87B | 2.39% | 507,079 | 2.53B |
| 74 | SMMT | Summit Therapeutics Inc. | 14.58B | -2.13% | 2,088,787 | - |
| 75 | ASND | Ascendis Pharma A/S | 14.41B | 5.77% | 754,917 | 845.52M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 14.37B | 3.07% | 1,441,432 | 502.08M |
| 77 | RGC | Regencell Bioscience Holdings Limited | 14.28B | 3.66% | 120,366 | - |
| 78 | PODD | Insulet Corporation | 14.10B | 0.52% | 702,934 | 2.71B |
| 79 | SNN | Smith & Nephew plc | 14.07B | 4.10% | 804,306 | 6.16B |
| 80 | COO | The Cooper Companies, Inc. | 14.00B | 2.97% | 2,235,881 | 4.15B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.36B | 1.72% | 1,216,019 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 13.02B | 0.34% | 377,321 | 1.40B |
| 83 | FMS | Fresenius Medical Care AG | 12.72B | 2.99% | 489,903 | 23.05B |
| 84 | ALGN | Align Technology, Inc. | 12.66B | 5.97% | 927,387 | 4.03B |
| 85 | GMED | Globus Medical, Inc. | 12.44B | 2.18% | 1,487,565 | 2.94B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.39B | 1.48% | 1,266,771 | 943.71M |
| 87 | GH | Guardant Health, Inc. | 12.18B | -0.49% | 1,690,732 | 982.02M |
| 88 | JAZZ | Jazz Pharmaceuticals plc | 12.06B | 2.61% | 1,017,397 | 4.27B |
| 89 | ENSG | The Ensign Group, Inc. | 11.96B | 2.20% | 427,283 | 5.06B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.92B | 1.54% | 345,605 | 958.40M |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.73B | 3.51% | 5,221,197 | 4.72B |
| 92 | EXEL | Exelixis, Inc. | 11.48B | 0.48% | 2,629,277 | 2.32B |
| 93 | UHS | Universal Health Services, Inc. | 11.41B | 3.41% | 561,887 | 17.36B |
| 94 | SOLV | Solventum Corporation | 11.31B | 4.42% | 1,500,255 | 8.33B |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.00B | 1.74% | 1,561,196 | 3.22B |
| 96 | RDY | Dr. Reddy's Laboratories Limited | 10.73B | 2.24% | 3,336,083 | 3.85B |
| 97 | EHC | Encompass Health Corporation | 10.62B | 1.08% | 1,589,233 | 5.94B |
| 98 | RVTY | Revvity, Inc. | 10.11B | 2.97% | 1,188,205 | 2.86B |
| 99 | DVA | DaVita Inc. | 9.91B | -0.84% | 737,387 | 13.64B |
| 100 | BTSG | BrightSpring Health Services, Inc. | 9.45B | 5.56% | 3,112,163 | 12.91B |
| 101 | ABVX | ABIVAX Société Anonyme | 9.35B | 2.13% | 438,838 | 5.37M |
| 102 | MASI | Masimo Corporation | 9.31B | -0.24% | 787,702 | 1.53B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.01B | 5.20% | 1,839,290 | 1.09B |
| 104 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | 4.41% | 328,555 | 7.46M |
| 105 | BAX | Baxter International Inc. | 8.90B | 3.73% | 6,358,472 | 11.24B |
| 106 | AXSM | Axsome Therapeutics, Inc. | 8.86B | 2.64% | 524,925 | 638.50M |
| 107 | HSIC | Henry Schein, Inc. | 8.66B | 2.27% | 1,509,473 | 13.18B |
| 108 | PCVX | Vaxcyte, Inc. | 8.65B | -0.97% | 1,511,453 | - |
| 109 | TECH | Bio-Techne Corporation | 8.64B | 2.56% | 2,011,250 | 1.22B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.62B | 3.26% | 978,959 | 4.02B |
| 111 | QGEN | Qiagen N.V. | 8.53B | 2.84% | 1,414,408 | 2.09B |
| 112 | TEM | Tempus AI, Inc. | 8.49B | 1.45% | 4,442,001 | 1.27B |
| 113 | ATR | AptarGroup, Inc. | 8.42B | 5.10% | 645,206 | 3.78B |
| 114 | NUVL | Nuvalent, Inc. | 8.26B | 2.73% | 370,481 | - |
| 115 | ICLR | ICON Public Limited Company | 8.14B | -0.58% | 784,772 | 8.10B |
| 116 | CYTK | Cytokinetics, Incorporated | 8.10B | 0.44% | 1,755,975 | 88.04M |
| 117 | KRYS | Krystal Biotech, Inc. | 7.78B | 0.09% | 298,393 | 389.13M |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.75B | 2.88% | 1,670,755 | 1.40B |
| 119 | MOH | Molina Healthcare, Inc. | 7.69B | 4.25% | 1,231,897 | 43.56B |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.59B | 1.13% | 388,929 | 2.58B |
| 121 | IBRX | ImmunityBio, Inc. | 7.21B | 1.75% | 16,541,532 | 113.29M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.11B | 2.39% | 514,353 | 39.21M |
| 123 | BLTE | Belite Bio, Inc | 7.03B | 5.27% | 163,965 | - |
| 124 | HQY | HealthEquity, Inc. | 6.92B | 1.07% | 1,128,977 | 1.31B |
| 125 | GKOS | Glaukos Corporation | 6.89B | 3.09% | 799,013 | 507.44M |
| 126 | GRFS | Grifols, S.A. | 6.83B | 3.58% | 297,614 | 8.83B |
| 127 | RGEN | Repligen Corporation | 6.75B | 3.89% | 758,363 | 738.26M |
| 128 | ACLX | Arcellx, Inc. | 6.74B | -0.01% | 629,428 | 22.29M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.51B | -1.60% | 819,198 | 46.02M |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.14B | -0.19% | 788,280 | - |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.05% | 3,464,023 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.08% | 12,994,123 | - |
| 133 | COGT | Cogent Biosciences, Inc. | 5.95B | 3.73% | 2,228,789 | - |
| 134 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | 2.40% | 702,862 | 521.31M |
| 135 | PTCT | PTC Therapeutics, Inc. | 5.90B | 2.41% | 907,063 | 1.73B |
| 136 | BLCO | Bausch + Lomb Corporation | 5.86B | 3.89% | 279,760 | 5.10B |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.84B | -1.36% | 981,645 | 189.76M |
| 138 | BRKR | Bruker Corporation | 5.82B | 4.31% | 1,612,473 | 3.44B |
| 139 | CGON | CG Oncology, Inc. | 5.82B | -1.35% | 1,219,405 | 4.04M |
| 140 | ALKS | Alkermes plc | 5.78B | 5.30% | 3,228,916 | 1.48B |
| 141 | SRRK | Scholar Rock Holding Corporation | 5.74B | 0.18% | 1,204,807 | - |
| 142 | CELC | Celcuity Inc. | 5.65B | 1.19% | 562,050 | - |
| 143 | PACS | PACS Group, Inc. | 5.56B | 9.03% | 910,214 | 5.29B |
| 144 | CAI | Caris Life Sciences, Inc. | 5.51B | 4.05% | 1,533,824 | 812.03M |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 5.49B | -0.19% | 819,723 | 7.50M |
| 146 | CHE | Chemed Corporation | 5.44B | 1.62% | 393,650 | 2.53B |
| 147 | AVTR | Avantor, Inc. | 5.41B | - | 9,879,368 | 6.55B |
| 148 | ERAS | Erasca, Inc. | 5.26B | -0.70% | 3,840,407 | - |
| 149 | TFX | Teleflex Incorporated | 5.26B | 3.05% | 691,751 | 1.99B |
| 150 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | -0.02% | 4,584,173 | 1.00B |
| 151 | LNTH | Lantheus Holdings, Inc. | 5.20B | 2.50% | 1,044,841 | 1.54B |
| 152 | TGTX | TG Therapeutics, Inc. | 5.05B | 2.46% | 1,639,041 | 616.29M |
| 153 | IMVT | Immunovant, Inc. | 5.03B | 0.49% | 1,326,740 | - |
| 154 | CRSP | CRISPR Therapeutics AG | 4.97B | 4.14% | 1,723,540 | 3.51M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.63B | 1.48% | 1,033,306 | 2.04M |
| 156 | OPCH | Option Care Health, Inc. | 4.56B | 5.12% | 2,846,660 | 5.65B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.07% | 2,982,764 | 634.21M |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.45B | 0.43% | 1,607,270 | 761.41M |
| 159 | HIMS | Hims & Hers Health, Inc. | 4.42B | -0.56% | 20,079,201 | 2.35B |
| 160 | NVST | Envista Holdings Corporation | 4.37B | 5.42% | 3,096,570 | 2.72B |
| 161 | OSCR | Oscar Health, Inc. | 4.35B | 12.88% | 15,140,780 | 11.70B |
| 162 | ALHC | Alignment Healthcare, Inc. | 4.35B | -1.62% | 4,986,744 | 3.95B |
| 163 | WAY | Waystar Holding Corp. | 4.34B | -0.92% | 2,870,721 | 1.10B |
| 164 | RDNT | RadNet, Inc. | 4.34B | 2.44% | 938,951 | 2.04B |
| 165 | SHC | Sotera Health Company | 4.33B | 4.10% | 3,393,522 | 1.16B |
| 166 | BLLN | BillionToOne, Inc. | 4.23B | 3.99% | 317,432 | 305.11M |
| 167 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.18B | 4.04% | 1,355,079 | 7.70M |
| 168 | LGND | Ligand Pharmaceuticals Incorporated | 4.15B | 1.46% | 233,279 | 268.09M |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.12B | 2.73% | 648,751 | 1.52B |
| 170 | SYRE | Spyre Therapeutics, Inc. | 4.08B | 1.52% | 1,043,910 | - |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 4.05B | 3.17% | 1,937,515 | 3.02B |
| 172 | DOCS | Doximity, Inc. | 4.04B | -2.84% | 3,430,878 | 637.78M |
| 173 | NAMS | NewAmsterdam Pharma Company N.V. | 3.91B | 0.29% | 954,650 | 22.50M |
| 174 | VKTX | Viking Therapeutics, Inc. | 3.90B | -0.09% | 1,794,272 | - |
| 175 | IRTC | iRhythm Holdings, Inc. | 3.89B | 1.57% | 462,110 | 747.14M |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 2.13% | 1,640,624 | 1.07B |
| 177 | MMED | Minimed Group, Inc. | 3.81B | 2.73% | 692,563 | 2.89B |
| 178 | STVN | Stevanato Group S.p.A. | 3.76B | 1.10% | 536,391 | 1.39B |
| 179 | GPCR | Structure Therapeutics Inc. | 3.76B | -2.87% | 852,360 | - |
| 180 | TMDX | TransMedics Group, Inc. | 3.75B | 1.90% | 1,019,916 | 605.49M |
| 181 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.60B | -3.90% | 651,112 | 677.56M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.54B | 1.66% | 681,629 | - |
| 183 | LIVN | LivaNova PLC | 3.54B | 1.76% | 1,024,341 | 1.39B |
| 184 | LEGN | Legend Biotech Corporation | 3.38B | 1.72% | 2,267,661 | 1.03B |
| 185 | LQDA | Liquidia Corporation | 3.37B | 2.22% | 950,064 | 158.32M |
| 186 | BKD | Brookdale Senior Living Inc. | 3.36B | 2.69% | 2,570,265 | 3.05B |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.26B | 1.56% | 103,739 | 803.79M |
| 188 | TWST | Twist Bioscience Corporation | 3.14B | 2.09% | 1,064,064 | 391.56M |
| 189 | DNLI | Denali Therapeutics Inc. | 3.11B | 1.08% | 1,116,426 | - |
| 190 | ICUI | ICU Medical, Inc. | 3.10B | 3.41% | 250,932 | 2.23B |
| 191 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.09B | 1.28% | 1,347,261 | 588.99M |
| 192 | ORKA | Oruka Therapeutics, Inc. | 3.07B | 2.33% | 1,545,994 | - |
| 193 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | 4.55% | 497,055 | 451.36M |
| 194 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | 5.76% | 1,170,000 | 376.07M |
| 195 | DYN | Dyne Therapeutics, Inc. | 3.03B | 1.21% | 1,121,507 | - |
| 196 | HNGE | Hinge Health, Inc. | 3.02B | 0.71% | 479,216 | 587.86M |
| 197 | ITGR | Integer Holdings Corporation | 2.98B | 2.78% | 323,031 | 1.85B |
| 198 | SUPN | Supernus Pharmaceuticals, Inc. | 2.97B | 1.28% | 618,498 | 718.95M |
| 199 | TXG | 10x Genomics, Inc. | 2.94B | 5.50% | 2,636,060 | 642.82M |
| 200 | TVTX | Travere Therapeutics, Inc. | 2.93B | 0.03% | 1,198,481 | 490.73M |
| 201 | ALMS | Alumis Inc. | 2.89B | 1.79% | 1,285,857 | 24.05M |
| 202 | VERA | Vera Therapeutics, Inc. | 2.88B | 0.82% | 1,223,152 | - |
| 203 | TNGX | Tango Therapeutics, Inc. | 2.86B | 1.31% | 2,453,105 | 62.38M |
| 204 | PRVA | Privia Health Group, Inc. | 2.85B | 1.47% | 1,279,708 | 2.12B |
| 205 | RCUS | Arcus Biosciences, Inc. | 2.84B | 2.63% | 1,060,944 | 247.00M |
| 206 | CON | Concentra Group Holdings Parent, Inc. | 2.82B | 2.72% | 651,533 | 2.16B |
| 207 | HAE | Haemonetics Corporation | 2.77B | -0.05% | 904,011 | 1.32B |
| 208 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.48% | 14,092,194 | 190.41M |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 2.72B | 0.16% | 1,704,620 | 218.71M |
| 210 | NHC | National HealthCare Corporation | 2.69B | 3.58% | 148,233 | 1.52B |
| 211 | PBH | Prestige Consumer Healthcare Inc. | 2.63B | -0.11% | 696,233 | 1.10B |
| 212 | WRBY | Warby Parker Inc. | 2.61B | 0.52% | 2,470,226 | 871.91M |
| 213 | VCYT | Veracyte, Inc. | 2.60B | 1.62% | 826,015 | 517.15M |
| 214 | RLAY | Relay Therapeutics, Inc. | 2.59B | 7.64% | 5,620,992 | 15.36M |
| 215 | KOD | Kodiak Sciences Inc. | 2.58B | 0.02% | 891,951 | - |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.57B | -0.53% | 1,199,766 | - |
| 217 | LMAT | LeMaitre Vascular, Inc. | 2.56B | 1.89% | 218,436 | 249.60M |
| 218 | LFST | LifeStance Health Group, Inc. | 2.55B | 2.03% | 1,933,962 | 1.42B |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.54B | 3.38% | 1,776,803 | 1.55M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | 1.96% | 932,673 | 1.45B |
| 221 | IRON | Disc Medicine, Inc. | 2.53B | -0.87% | 334,533 | - |
| 222 | BEAM | Beam Therapeutics Inc. | 2.53B | 3.88% | 1,852,695 | 139.74M |
| 223 | HCM | HUTCHMED (China) Limited | 2.50B | -2.66% | 37,849 | 548.51M |
| 224 | IMNM | Immunome, Inc. | 2.45B | 0.56% | 1,339,558 | 6.94M |
| 225 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.45B | 1.98% | 8,649,238 | 874.84M |
| 226 | ACHC | Acadia Healthcare Company, Inc. | 2.42B | 3.62% | 3,368,723 | 3.31B |
| 227 | ZLAB | Zai Lab Limited | 2.41B | 1.86% | 1,071,047 | 460.16M |
| 228 | AAPG | Ascentage Pharma Group International | 2.40B | -2.82% | 983 | 82.08M |
| 229 | XRAY | DENTSPLY SIRONA Inc. | 2.39B | 4.08% | 4,318,803 | 3.68B |
| 230 | PAHC | Phibro Animal Health Corporation | 2.38B | 5.39% | 387,116 | 1.46B |
| 231 | ADMA | ADMA Biologics, Inc. | 2.34B | 6.16% | 5,538,378 | 510.17M |
| 232 | HTFL | HeartFlow, Inc. | 2.32B | 0.78% | 1,071,029 | 176.03M |
| 233 | SRPT | Sarepta Therapeutics, Inc. | 2.30B | -5.11% | 2,717,562 | 2.20B |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -1.94% | 837,288 | - |
| 235 | ADPT | Adaptive Biotechnologies Corporation | 2.29B | 8.24% | 2,188,851 | 276.98M |
| 236 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | - | 1,615,498 | 673.00M |
| 237 | NEOG | Neogen Corporation | 2.25B | 3.61% | 3,834,920 | 880.32M |
| 238 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.09% | 1,522,672 | 158.18M |
| 239 | MANE | Veradermics, Incorporated | 2.17B | 2.35% | 439,570 | - |
| 240 | SNDX | Syndax Pharmaceuticals, Inc. | 2.17B | -0.32% | 1,730,151 | 172.35M |
| 241 | NKTR | Nektar Therapeutics | 2.15B | -1.52% | 756,140 | 55.23M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 0.63% | 843,951 | 283.06M |
| 243 | DFTX | Definium Therapeutics, Inc. | 2.10B | 2.14% | 1,277,303 | - |
| 244 | GRAL | GRAIL, Inc. | 2.08B | 3.32% | 2,217,506 | 147.17M |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.06B | 3.23% | 1,245,922 | 184.42M |
| 246 | SEM | Select Medical Holdings Corporation | 2.03B | - | 1,687,654 | 5.45B |
| 247 | TYRA | Tyra Biosciences, Inc. | 2.00B | -1.59% | 857,684 | - |
| 248 | BHC | Bausch Health Companies Inc. | 1.98B | 1.71% | 1,183,925 | 10.27B |
| 249 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -3.82% | 1,236,137 | 54.03M |
| 250 | ZYME | Zymeworks Inc. | 1.97B | 2.73% | 1,043,267 | 105.97M |
| 251 | AHG | Akso Health Group | 1.96B | 0.44% | 165,249 | 14.84M |
| 252 | WGS | GeneDx Holdings Corp. | 1.92B | -1.94% | 543,082 | 427.54M |
| 253 | GLPG | Galapagos NV | 1.89B | -0.14% | 92,737 | 1.31B |
| 254 | ANAB | AnaptysBio, Inc. | 1.88B | 5.49% | 565,659 | 234.60M |
| 255 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.87B | 4.00% | 1,536,960 | -665.00K |
| 256 | MESO | Mesoblast Limited | 1.85B | 1.68% | 344,970 | 65.38M |
| 257 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 0.96% | 4,028,946 | 51.95M |
| 258 | ESTA | Establishment Labs Holdings Inc. | 1.82B | 5.08% | 446,550 | 211.08M |
| 259 | CAPR | Capricor Therapeutics, Inc. | 1.82B | -1.16% | 639,979 | 11.13M |
| 260 | PHVS | Pharvaris N.V. | 1.80B | -1.01% | 202,429 | - |
| 261 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | 6.27% | 15,676,952 | 74.68M |
| 262 | ATEC | Alphatec Holdings, Inc. | 1.76B | 5.71% | 2,355,836 | 764.16M |
| 263 | AXGN | Axogen, Inc. | 1.76B | 9.71% | 1,530,191 | 225.21M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 1.76B | 2.62% | 280,434 | - |
| 265 | INVA | Innoviva, Inc. | 1.75B | 1.46% | 650,159 | 411.33M |
| 266 | AORT | Artivion, Inc. | 1.75B | 2.39% | 765,209 | 441.33M |
| 267 | MD | Pediatrix Medical Group, Inc. | 1.73B | -1.66% | 891,992 | 1.91B |
| 268 | VCEL | Vericel Corporation | 1.73B | 2.10% | 493,627 | 276.26M |
| 269 | TRVI | Trevi Therapeutics, Inc. | 1.68B | -0.23% | 1,077,368 | - |
| 270 | ADUS | Addus HomeCare Corporation | 1.67B | -0.91% | 381,359 | 1.42B |
| 271 | SION | Sionna Therapeutics, Inc. | 1.66B | 0.52% | 274,361 | - |
| 272 | AHCO | AdaptHealth Corp. | 1.66B | 2.01% | 1,177,786 | 3.24B |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -0.58% | 716,281 | 883.37M |
| 274 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | 3.08% | 887,688 | 868.45M |
| 275 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 2.36% | 3,015,570 | 67.67M |
| 276 | SGRY | Surgery Partners, Inc. | 1.62B | 0.08% | 1,500,617 | 3.31B |
| 277 | OCS | Oculis Holding AG | 1.62B | 3.56% | 145,668 | 1.51M |
| 278 | OMCL | Omnicell, Inc. | 1.62B | 3.10% | 390,888 | 1.18B |
| 279 | IMCR | Immunocore Holdings plc | 1.61B | -0.34% | 488,625 | 400.02M |
| 280 | NRIX | Nurix Therapeutics, Inc. | 1.61B | -4.59% | 2,005,201 | 71.78M |
| 281 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 0.60% | 136,548 | - |
| 282 | NUVB | Nuvation Bio Inc. | 1.55B | 0.44% | 3,394,806 | 62.90M |
| 283 | UFPT | UFP Technologies, Inc. | 1.55B | 6.25% | 238,710 | 602.80M |
| 284 | DMRA | Damora Therapeutics, Inc. | 1.54B | 4.92% | 151,308 | - |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.54B | -1.91% | 860,768 | 911.98M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.53B | 2.37% | 645,729 | 336.39M |
| 287 | OGN | Organon & Co. | 1.53B | -4.25% | 4,985,562 | 6.22B |
| 288 | GENB | Generate Biomedicines, Inc. | 1.52B | 0.93% | 390,153 | 31.89M |
| 289 | VIR | Vir Biotechnology, Inc. | 1.52B | 3.82% | 2,512,437 | 68.56M |
| 290 | SVRA | Savara Inc. | 1.50B | 2.77% | 1,183,163 | - |
| 291 | MBX | MBX Biosciences, Inc. | 1.50B | 4.87% | 453,999 | - |
| 292 | ARDX | Ardelyx, Inc. | 1.50B | 2.52% | 3,052,815 | 407.32M |
| 293 | PRGO | Perrigo Company plc | 1.49B | 2.56% | 3,360,409 | 4.25B |
| 294 | VRDN | Viridian Therapeutics, Inc. | 1.48B | 3.65% | 4,593,416 | 70.85M |
| 295 | NBTX | Nanobiotix S.A. | 1.47B | 2.22% | 93,102 | 38.27M |
| 296 | PGEN | Precigen, Inc. | 1.46B | - | 5,499,712 | 9.68M |
| 297 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | 2.79% | 2,037,401 | 2.43B |
| 298 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | 4.52% | 15,629,660 | 263.50M |
| 299 | ATRC | AtriCure, Inc. | 1.43B | -2.32% | 1,148,877 | 534.53M |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.41B | 1.50% | 340,569 | - |
| 301 | IMTX | Immatics N.V. | 1.41B | 2.73% | 406,692 | 56.67M |
| 302 | BHVN | Biohaven Ltd. | 1.41B | 1.30% | 1,256,295 | - |
| 303 | MAZE | Maze Therapeutics, Inc. | 1.40B | -0.85% | 927,080 | 2.50M |
| 304 | NVAX | Novavax, Inc. | 1.37B | 5.51% | 3,730,130 | 1.12B |
| 305 | ATAI | AtaiBeckley Inc. | 1.37B | -0.79% | 5,094,431 | 4.09M |
| 306 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | - | 1,151,924 | 123.67M |
| 307 | ENOV | Enovis Corporation | 1.37B | 5.64% | 779,906 | 2.25B |
| 308 | OLMA | Olema Pharmaceuticals, Inc. | 1.37B | 2.89% | 925,454 | - |
| 309 | HROW | Harrow, Inc. | 1.37B | 3.67% | 583,018 | 272.30M |
| 310 | ASTH | Astrana Health, Inc. | 1.36B | -1.23% | 477,458 | 3.18B |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.35B | 2.02% | 1,285,378 | 1.84B |
| 312 | PRCT | PROCEPT BioRobotics Corporation | 1.35B | 2.93% | 1,836,251 | 308.05M |
| 313 | WVE | Wave Life Sciences Ltd. | 1.34B | - | 2,457,432 | 42.73M |
| 314 | MLTX | MoonLake Immunotherapeutics | 1.33B | 8.90% | 1,839,318 | - |
| 315 | ARDT | Ardent Health, Inc. | 1.33B | 3.44% | 589,433 | 6.32B |
| 316 | PGNY | Progyny, Inc. | 1.33B | -1.34% | 1,442,505 | 1.29B |
| 317 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 5.85% | 1,919,490 | 1.01B |
| 318 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | -0.44% | 2,314,926 | 9.77M |
| 319 | PLSE | Pulse Biosciences, Inc. | 1.30B | -4.51% | 323,481 | 350.00K |
| 320 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | 3.69% | 681,583 | - |
| 321 | IRMD | IRADIMED CORPORATION | 1.24B | 4.11% | 183,400 | 83.81M |
| 322 | ZBIO | Zenas BioPharma, Inc. | 1.24B | -7.21% | 837,212 | 10.00M |
| 323 | NVCR | NovoCure Limited | 1.23B | 4.25% | 1,194,775 | 655.35M |
| 324 | PHAR | Pharming Group N.V. | 1.21B | 3.41% | 25,285 | 376.13M |
| 325 | DBVT | DBV Technologies S.A. | 1.19B | 5.18% | 118,791 | 5.64M |
| 326 | NNNN | Anbio Biotechnology | 1.18B | -1.57% | 22,159 | 8.65M |
| 327 | EYPT | EyePoint, Inc. | 1.18B | 4.42% | 1,084,778 | 31.37M |
| 328 | USPH | U.S. Physical Therapy, Inc. | 1.16B | 2.51% | 186,234 | 773.34M |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.15B | 0.67% | 395,003 | 83.72M |
| 330 | INNV | InnovAge Holding Corp. | 1.13B | 5.83% | 335,286 | 915.37M |
| 331 | CNMD | CONMED Corporation | 1.13B | 5.94% | 482,905 | 1.37B |
| 332 | ALVO | Alvotech | 1.12B | 5.60% | 393,835 | 588.90M |
| 333 | AVBP | ArriVent BioPharma, Inc. | 1.12B | 0.24% | 489,648 | - |
| 334 | SEPN | Septerna, Inc. | 1.10B | -1.41% | 162,439 | 45.95M |
| 335 | GERN | Geron Corporation | 1.10B | -1.72% | 20,090,979 | 183.88M |
| 336 | PNTG | The Pennant Group, Inc. | 1.08B | 1.51% | 276,078 | 947.71M |
| 337 | NEO | NeoGenomics, Inc. | 1.07B | 1.99% | 1,511,806 | 727.33M |
| 338 | MPLT | MapLight Therapeutics, Inc. | 1.07B | 0.41% | 390,340 | - |
| 339 | COLL | Collegium Pharmaceutical, Inc. | 1.06B | 2.05% | 791,558 | 780.57M |
| 340 | BFLY | Butterfly Network, Inc. | 1.05B | 2.22% | 2,977,209 | 97.61M |
| 341 | QDEL | QuidelOrtho Corporation | 1.04B | 2.27% | 1,404,707 | 2.73B |
| 342 | ABCL | AbCellera Biologics Inc. | 1.04B | 3.94% | 2,466,194 | 75.13M |
| 343 | STAA | STAAR Surgical Company | 1.03B | -1.00% | 1,156,493 | 239.44M |
| 344 | AZTA | Azenta, Inc. | 1.03B | 2.72% | 1,105,634 | 595.03M |
| 345 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | 0.85% | 2,340,786 | 291.85M |
| 346 | IVA | Inventiva S.A. | 1.02B | -0.75% | 226,695 | 9.31M |
| 347 | CLOV | Clover Health Investments, Corp. | 1.01B | 1.05% | 5,961,788 | 1.92B |
| 348 | QURE | uniQure N.V. | 993.59M | -7.29% | 1,452,006 | 16.10M |
| 349 | KALV | KalVista Pharmaceuticals, Inc. | 987.06M | -4.22% | 840,708 | 73.62M |
| 350 | INBX | Inhibrx Biosciences, Inc. | 980.57M | 7.67% | 334,202 | 1.30M |
| 351 | EVMN | Evommune, Inc. | 977.18M | 9.44% | 439,199 | 13.00M |
| 352 | CMPX | Compass Therapeutics, Inc. | 972.47M | 1.69% | 3,059,872 | 850.00K |
| 353 | ANNX | Annexon, Inc. | 970.87M | 1.00% | 2,468,283 | - |
| 354 | EVO | Evotec SE | 969.55M | 4.26% | 95,259 | 925.65M |
| 355 | CRON | Cronos Group Inc. | 966.26M | 0.40% | 654,246 | 146.59M |
| 356 | BLFS | BioLife Solutions, Inc. | 951.99M | 3.03% | 351,124 | 96.21M |
| 357 | PCRX | Pacira BioSciences, Inc. | 941.39M | 3.20% | 860,983 | 726.41M |
| 358 | TDOC | Teladoc Health, Inc. | 940.15M | -0.94% | 4,480,383 | 2.53B |
| 359 | AKTS | Aktis Oncology, Inc. | 938.59M | 1.56% | 215,515 | 6.50M |
| 360 | PHAT | Phathom Pharmaceuticals, Inc. | 930.61M | 2.25% | 920,982 | 175.11M |
| 361 | URGN | UroGen Pharma Ltd. | 929.83M | 5.93% | 817,186 | 109.79M |
| 362 | GHRS | GH Research PLC | 929.82M | 2.11% | 60,348 | - |
| 363 | AMPH | Amphastar Pharmaceuticals, Inc. | 925.55M | -0.87% | 613,466 | 719.89M |
| 364 | CTMX | CytomX Therapeutics, Inc. | 918.75M | -1.16% | 6,317,795 | 76.20M |
| 365 | CDNA | CareDx, Inc. | 917.80M | 1.41% | 713,196 | 379.81M |
| 366 | LMRI | Lumexa Imaging Holdings, Inc. | 914.97M | 5.54% | 1,000,180 | 1.02B |
| 367 | ORIC | ORIC Pharmaceuticals, Inc. | 908.24M | 2.03% | 1,695,368 | - |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 905.47M | 0.67% | 611,622 | - |
| 369 | OPK | OPKO Health, Inc. | 903.29M | 1.71% | 2,916,973 | 606.88M |
| 370 | FTRE | Fortrea Holdings Inc. | 900.41M | 1.26% | 1,130,578 | 2.72B |
| 371 | XNCR | Xencor, Inc. | 898.40M | -0.49% | 974,757 | 125.58M |
| 372 | JANX | Janux Therapeutics, Inc. | 883.88M | -2.68% | 704,177 | 10.00M |
| 373 | INMD | InMode Ltd. | 873.08M | 0.95% | 556,013 | 370.50M |
| 374 | SLS | SELLAS Life Sciences Group, Inc. | 872.77M | 7.76% | 4,098,085 | - |
| 375 | TALK | Talkspace, Inc. | 862.11M | - | 2,170,017 | 228.87M |
| 376 | SSII | SS Innovations International, Inc. | 859.74M | -10.04% | 69,795 | 42.48M |
| 377 | SANA | Sana Biotechnology, Inc. | 856.64M | 1.90% | 2,081,671 | - |
| 378 | ABUS | Arbutus Biopharma Corporation | 856.19M | -1.79% | 1,967,821 | 14.08M |
| 379 | TBPH | Theravance Biopharma, Inc. | 854.78M | 0.24% | 285,394 | 107.46M |
| 380 | VOR | Vor Biopharma Inc. | 853.15M | -6.56% | 1,824,577 | - |
| 381 | SDGR | Schrödinger, Inc. | 848.99M | 0.97% | 1,383,275 | 255.87M |
| 382 | CERT | Certara, Inc. | 832.56M | -3.38% | 3,774,567 | 418.84M |
| 383 | OMER | Omeros Corporation | 828.68M | 4.83% | 1,191,210 | - |
| 384 | JBIO | Jade Biosciences, Inc. | 826.54M | 2.44% | 502,098 | - |
| 385 | SPRY | ARS Pharmaceuticals, Inc. | 813.24M | 0.49% | 1,831,087 | 84.28M |
| 386 | DRUG | Bright Minds Biosciences Inc. | 805.65M | 7.66% | 259,034 | - |
| 387 | MNKD | MannKind Corporation | 804.14M | 1.56% | 4,471,318 | 348.97M |
| 388 | BIOA | BioAge Labs, Inc. | 800.61M | 2.44% | 399,372 | 9.00M |
| 389 | MRVI | Maravai LifeSciences Holdings, Inc. | 799.48M | 7.61% | 1,850,508 | 185.74M |
| 390 | SLDB | Solid Biosciences Inc. | 789.10M | 3.62% | 644,341 | - |
| 391 | TLRY | Tilray Brands, Inc. | 784.53M | 4.49% | 3,160,588 | 858.28M |
| 392 | DSGN | Design Therapeutics, Inc. | 781.39M | 3.68% | 312,585 | - |
| 393 | KURA | Kura Oncology, Inc. | 776.42M | -0.34% | 1,046,034 | 67.48M |
| 394 | MGTX | MeiraGTx Holdings plc | 764.78M | -1.26% | 804,333 | 81.39M |
| 395 | BVS | Bioventus Inc. | 760.03M | 3.39% | 309,758 | 568.09M |
| 396 | TENX | Tenax Therapeutics, Inc. | 757.02M | 3.15% | 526,994 | - |
| 397 | IART | Integra LifeSciences Holdings Corporation | 749.76M | 3.11% | 835,519 | 1.64B |
| 398 | CSTL | Castle Biosciences, Inc. | 748.93M | 1.45% | 418,651 | 344.23M |
| 399 | SGP | SpyGlass Pharma, Inc. | 742.74M | 5.46% | 147,973 | - |
| 400 | OMDA | Omada Health, Inc. | 738.34M | 1.05% | 580,498 | 260.21M |
| 401 | CMPS | COMPASS Pathways plc | 737.44M | 3.25% | 1,405,844 | - |
| 402 | RLMD | Relmada Therapeutics, Inc. | 735.27M | 3.85% | 683,707 | - |
| 403 | AMN | AMN Healthcare Services, Inc. | 733.70M | 1.88% | 661,540 | 2.73B |
| 404 | GDRX | GoodRx Holdings, Inc. | 733.11M | 4.39% | 1,041,422 | 796.85M |
| 405 | NUTX | Nutex Health Inc. | 731.96M | 2.08% | 210,242 | 875.26M |
| 406 | ETON | Eton Pharmaceuticals, Inc. | 720.17M | 5.33% | 476,278 | 79.95M |
| 407 | ARVN | Arvinas, Inc. | 717.00M | -1.41% | 700,335 | 262.60M |
| 408 | EHAB | Enhabit, Inc. | 709.62M | - | 993,517 | 1.06B |
| 409 | LXRX | Lexicon Pharmaceuticals, Inc. | 707.55M | 4.37% | 2,303,384 | 49.80M |
| 410 | CBLL | CeriBell, Inc. | 703.14M | 4.53% | 209,332 | 89.06M |
| 411 | ANRO | Alto Neuroscience, Inc. | 693.54M | 1.69% | 267,544 | - |
| 412 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 691.48M | 2.86% | 421,276 | - |
| 413 | PSNL | Personalis, Inc. | 662.61M | 2.59% | 1,727,192 | 69.65M |
| 414 | ALLO | Allogene Therapeutics, Inc. | 658.20M | 3.05% | 3,578,071 | 22.00K |
| 415 | LBRX | LB Pharmaceuticals Inc | 657.27M | 2.69% | 181,876 | - |
| 416 | GYRE | Gyre Therapeutics, Inc. | 647.42M | -0.42% | 93,177 | 116.59M |
| 417 | AVNS | Avanos Medical, Inc. | 647.39M | 1.68% | 369,403 | 701.20M |
| 418 | DRTS | Alpha Tau Medical Ltd. | 633.67M | 0.84% | 348,148 | - |
| 419 | OCGN | Ocugen, Inc. | 628.49M | 6.90% | 4,656,719 | 4.41M |
| 420 | PRME | Prime Medicine, Inc. | 626.86M | 3.81% | 1,732,064 | 4.63M |
| 421 | SIBN | SI-BONE, Inc. | 615.22M | 5.77% | 773,258 | 200.93M |
| 422 | CBIO | Crescent Biopharma, Inc. | 608.48M | -4.63% | 126,393 | 10.84M |
| 423 | CTKB | Cytek Biosciences, Inc. | 599.04M | 1.30% | 610,683 | 201.49M |
| 424 | ESPR | Esperion Therapeutics, Inc. | 598.37M | 0.87% | 4,422,765 | 403.14M |
| 425 | HSTM | HealthStream, Inc. | 596.81M | -1.07% | 201,256 | 304.06M |
| 426 | MDXG | MiMedx Group, Inc. | 589.81M | 2.85% | 1,648,206 | 418.63M |
| 427 | PRTA | Prothena Corporation plc | 573.32M | 2.80% | 454,454 | 9.68M |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 572.33M | 1.45% | 1,540,425 | 296.15M |
| 429 | CRMD | CorMedix Inc. | 571.53M | 0.84% | 883,094 | 311.71M |
| 430 | TECX | Tectonic Therapeutic, Inc. | 564.43M | 3.51% | 160,975 | - |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 563.04M | -0.93% | 568,274 | 106.47M |
| 432 | PROK | ProKidney Corp. | 558.54M | 1.09% | 695,939 | 893.00K |
| 433 | KYTX | Kyverna Therapeutics, Inc. | 557.40M | -1.18% | 911,182 | - |
| 434 | RIGL | Rigel Pharmaceuticals, Inc. | 549.21M | 3.48% | 385,388 | 294.28M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 549.19M | 0.37% | 343,519 | 329.52M |
| 436 | ACRS | Aclaris Therapeutics, Inc. | 549.03M | 5.33% | 873,276 | 7.83M |
| 437 | VALN | Valneva SE | 546.53M | 5.04% | 44,208 | 205.07M |
| 438 | BWAY | BrainsWay Ltd. | 544.09M | 7.91% | 266,660 | 52.23M |
| 439 | ZURA | Zura Bio Limited | 540.82M | 0.88% | 645,086 | - |
| 440 | UPB | Upstream Bio, Inc. | 535.49M | 1.44% | 474,364 | 2.85M |
| 441 | LYEL | Lyell Immunopharma, Inc. | 534.45M | 5.19% | 72,246 | 36.00K |
| 442 | PHR | Phreesia, Inc. | 531.68M | -3.42% | 1,865,340 | 480.59M |
| 443 | LRMR | Larimar Therapeutics, Inc. | 528.76M | 0.99% | 1,322,382 | - |
| 444 | FULC | Fulcrum Therapeutics, Inc. | 526.14M | 0.89% | 553,356 | 80.00M |
| 445 | EMBC | Embecta Corp. | 525.87M | 0.57% | 497,761 | 1.08B |
| 446 | FDMT | 4D Molecular Therapeutics, Inc. | 515.62M | -1.37% | 631,238 | 85.21M |
| 447 | TRDA | Entrada Therapeutics, Inc. | 515.52M | 3.39% | 157,182 | 25.42M |
| 448 | AVR | Anteris Technologies Global Corp. | 515.38M | 2.26% | 645,678 | 1.91M |
| 449 | EIKN | Eikon Therapeutics, Inc. | 514.32M | 8.20% | 459,222 | - |
| 450 | AQST | Aquestive Therapeutics, Inc. | 510.15M | 1.21% | 1,301,245 | 44.55M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 452 | STTK | Shattuck Labs, Inc. | 502.38M | 3.54% | 431,975 | 1.00M |
| 453 | NPCE | NeuroPace, Inc. | 498.27M | 2.00% | 105,258 | 99.99M |
| 454 | CATX | Perspective Therapeutics, Inc. | 497.89M | - | 499,686 | 884.00K |
| 455 | FBRX | Forte Biosciences, Inc. | 493.04M | 0.38% | 157,099 | - |
| 456 | OFIX | Orthofix Medical Inc. | 489.76M | 4.18% | 180,870 | 822.31M |
| 457 | ENGN | enGene Holdings Inc. | 489.69M | -0.27% | 117,706 | - |
| 458 | REPL | Replimune Group, Inc. | 485.94M | -24.55% | 6,345,127 | - |
| 459 | AGMB | AgomAb Therapeutics NV | 480.06M | -6.28% | 182,630 | - |
| 460 | VSTM | Verastem, Inc. | 478.70M | - | 1,215,471 | 30.91M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 477.53M | 0.47% | 135,024 | - |
| 462 | VTVT | vTv Therapeutics Inc. | 477.27M | 0.55% | 79,685 | 17.00K |
| 463 | LXEO | Lexeo Therapeutics, Inc. | 477.12M | 2.06% | 1,039,428 | - |
| 464 | KMDA | Kamada Ltd. | 476.75M | 2.67% | 24,782 | 180.46M |
| 465 | ADCT | ADC Therapeutics SA | 473.88M | 0.27% | 541,620 | 81.36M |
| 466 | AVIR | Atea Pharmaceuticals, Inc. | 472.46M | -0.67% | 408,862 | - |
| 467 | ASMB | Assembly Biosciences, Inc. | 465.57M | 2.87% | 115,746 | 72.30M |
| 468 | IMMX | Immix Biopharma, Inc. | 463.86M | -3.74% | 512,694 | - |
| 469 | VREX | Varex Imaging Corporation | 462.79M | 4.25% | 213,810 | 854.40M |
| 470 | ABSI | Absci Corporation | 457.53M | 2.40% | 3,208,402 | 2.80M |
| 471 | FLGT | Fulgent Genetics, Inc. | 456.61M | -0.50% | 373,772 | 322.67M |
| 472 | STRO | Sutro Biopharma, Inc. | 448.14M | 5.21% | 221,478 | 102.48M |
| 473 | RGNX | REGENXBIO Inc. | 447.52M | -1.48% | 587,385 | 170.44M |
| 474 | MYGN | Myriad Genetics, Inc. | 446.03M | 0.63% | 955,691 | 824.50M |
| 475 | ARMP | Armata Pharmaceuticals, Inc. | 443.99M | 1.42% | 113,425 | 4.90M |
| 476 | PACB | Pacific Biosciences of California, Inc. | 443.94M | 2.08% | 5,310,448 | 160.01M |
| 477 | ANL | Adlai Nortye Ltd. | 443.91M | 22.76% | 1,341,726 | -1.35M |
| 478 | AUNA | Auna S.A. | 439.64M | 2.24% | 170,216 | 1.30B |
| 479 | ALT | Altimmune, Inc. | 438.45M | -0.30% | 1,695,749 | 41.00K |
| 480 | BBNX | Beta Bionics, Inc. | 434.50M | 0.62% | 983,648 | 100.25M |
| 481 | AURA | Aura Biosciences, Inc. | 434.30M | 2.11% | 349,129 | - |
| 482 | EBS | Emergent BioSolutions Inc. | 433.30M | 6.88% | 635,572 | 742.90M |
| 483 | VNDA | Vanda Pharmaceuticals Inc. | 430.90M | -2.15% | 1,198,527 | 216.11M |
| 484 | ANGO | AngioDynamics, Inc. | 423.91M | 4.85% | 452,370 | 313.73M |
| 485 | EPRX | Eupraxia Pharmaceuticals Inc. | 420.16M | 1.62% | 140,266 | - |
| 486 | CYH | Community Health Systems, Inc. | 414.98M | 2.31% | 995,863 | 12.49B |
| 487 | XOMA | XOMA Royalty Corporation | 413.00M | 0.23% | 183,387 | 52.15M |
| 488 | IPSC | Century Therapeutics, Inc. | 411.57M | 1.33% | 1,283,340 | 109.16M |
| 489 | YDES | YD Bio Limited | 405.04M | -17.48% | 20,458 | 510.36K |
| 490 | KIDS | OrthoPediatrics Corp. | 404.71M | 1.59% | 125,981 | 236.35M |
| 491 | DNA | Ginkgo Bioworks Holdings, Inc. | 400.47M | 0.88% | 751,065 | 170.16M |
| 492 | ENTA | Enanta Pharmaceuticals, Inc. | 399.60M | 2.53% | 76,940 | 66.98M |
| 493 | NMRA | Neumora Therapeutics, Inc. | 396.85M | 2.35% | 1,280,409 | - |
| 494 | AUTL | Autolus Therapeutics plc | 396.55M | 9.56% | 1,823,882 | 75.39M |
| 495 | NAUT | Nautilus Biotechnology, Inc. | 396.15M | 0.32% | 349,822 | - |
| 496 | RCKT | Rocket Pharmaceuticals, Inc. | 392.84M | 3.45% | 2,374,637 | - |
| 497 | NRC | National Research Corporation | 392.60M | 1.29% | 82,435 | 137.39M |
| 498 | PRTC | PureTech Health plc | 391.19M | 1.03% | 2,773 | 6.39M |
| 499 | MNPR | Monopar Therapeutics Inc. | 388.34M | 8.24% | 98,078 | - |
| 500 | CGC | Canopy Growth Corporation | 387.76M | 4.83% | 17,880,557 | 203.04M |